The genetics underpinning resistance to a frontline malaria drug, artemisinin, have been revealed, scientists say.

In South East Asia, malaria parasites have developed tolerance to the treatment, and there are fears that this will spread.

Now, in the largest genetic study to date, scientists have identified mutations in the parasite genome that are linked to resistance.

The study is published in Nature Genetics.

The researchers say the findings will help them to identify areas where artemisinin resistance could spread.

Lead author Dr Olivo Miotto from the Mahidol-Oxford Tropical Research Unit (MORU), in Thailand, said: "Artemisinin is the best drug we have had for a very long time, and we want to continue this success story.

"And for that its effectiveness has to be protected and sustained."

When the first malaria drug, chloroquine, was developed, researchers thought that the disease would be eradicated within years.

But the malaria parasite has proved far tougher than they ever imagined. Drug after drug has been rendered useless as the parasite has evolved to evade treatment.

Mysteriously, each time resistance has emerged, it has started in the same place - on the Cambodia-Thai border - before spreading across Asia and into Africa.

Go here to see the original:
Genetics Of Malaria Drug Resistance Revealed

Comments are closed.